BELSOMRA 5 mg/1
suvorexant · TABLET, FILM COATED · Merck Sharp & Dohme LLC
No Recall History
Plain English
BELSOMRA is a tablet, film coated containing suvorexant at 5 mg/1, taken oral. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- BELSOMRA
- Generic Name
- suvorexant
- NDC Code (Product)
0006-0005- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA204569
- Drug Class
- Orexin Receptor Antagonist [EPC]
- Marketing Start
- 08/29/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is BELSOMRA used for?
BELSOMRA contains suvorexant. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is BELSOMRA a controlled substance?
Yes, BELSOMRA is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for BELSOMRA?
The generic name for BELSOMRA is suvorexant. There are no other listed brand versions of suvorexant.
What is the NDC code for BELSOMRA 5 mg/1?
The NDC (National Drug Code) for BELSOMRA 5 mg/1 is 0006-0005, listed by Merck Sharp & Dohme LLC.
Other BELSOMRA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)